ArticleCureus2025
The Interplay Between Visceral Adiposity and Cardiometabolic Risk in Children With Obesity.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionLately, pediatric obesity has become a global threat. It is associated with high morbidity and mortality rates from cardiometabolic diseases in young adults. The purpose of the study was to assess the correlation between visceral adipose tissue (VAT) thickness and cardiometabolic risk factors, including insulin resistance, in children and adolescents with obesity.
methodsA cross-sectional study was conducted on 46 children and adolescents with obesity, with a mean age of 10.26 ± 2.79, from the pediatric clinical nutrition unit of Ain Shams University Hospital, Cairo, Egypt. VAT thickness and subcutaneous adipose tissue (SAT) thickness were measured using ultrasound and correlated with anthropometric measures, fasting lipid profile, homeostasis model assessment for insulin resistance (HOMA-IR), and alanine transaminase (ALT).
resultsVAT thickness measured through ultrasound has demonstrated a positive correlation with body mass index (BMI) and HOMA-IR, with an area under the curve for VAT thickness as a predictor of insulin resistance being 0.858 and 2.98 cm as a cutoff point. In addition, VAT thickness positively correlates with serum triglyceride and ALT levels. Conversely, VAT thickness shows a negative correlation with HDL levels.
conclusionsVAT thickness measured by ultrasound may be regarded as a suitable prognostic factor for insulin resistance and cardiometabolic risks in children and adolescents with obesity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.